Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624442 · ClinicalTrials.gov registry record · Phase 2
A Study of CK-1827452 Infusion in Stable Heart Failure
A Phase 2 study, sponsored by Cytokinetics.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00624442 is a Phase 2 study that has completed, run by Cytokinetics. The registered enrollment target is 45 participants.
The verdict
NCT00624442, a Phase 2 study, has completed, sponsored by Cytokinetics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study will assess the safety, tolerability, and pharmacodynamics of CK-1827452 infusion in patients with stable heart failure.
Interventions
- DRUG CK-1827452
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624442
The ClinicalTrials.gov registry entry for NCT00624442 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cytokinetics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CK-1827452 is the first listed.
NCT00624442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00624442 about?
NCT00624442 is a clinical study titled "A Study of CK-1827452 Infusion in Stable Heart Failure". This study will assess the safety, tolerability, and pharmacodynamics of CK-1827452 infusion in patients with stable heart failure.
What is the current status of trial NCT00624442?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2007-04. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00624442?
The interventions under investigation include: CK-1827452 (DRUG).
Who is sponsoring clinical trial NCT00624442?
This trial is sponsored by Cytokinetics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.